BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 38551165)

  • 1. LPCAT1 promotes melanoma cell proliferation via Akt signaling.
    Wang Y; Huang Y; Wang Y; Zhang W; Wang N; Bai R; Luo R; Tuo H; Zheng Y
    Oncol Rep; 2024 May; 51(5):. PubMed ID: 38551165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LPCAT1 Promotes Cutaneous Squamous Cell Carcinoma via EGFR-Mediated Protein Kinase B/p38MAPK Signaling Pathways.
    Huang Y; Wang Y; Wang Y; Wang N; Duan Q; Wang S; Liu M; Bilal MA; Zheng Y
    J Invest Dermatol; 2022 Feb; 142(2):303-313.e9. PubMed ID: 34358528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LPCAT1 promotes brain metastasis of lung adenocarcinoma by up-regulating PI3K/AKT/MYC pathway.
    Wei C; Dong X; Lu H; Tong F; Chen L; Zhang R; Dong J; Hu Y; Wu G; Dong X
    J Exp Clin Cancer Res; 2019 Feb; 38(1):95. PubMed ID: 30791942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LPCAT1 functions as an oncogene in cervical cancer through mediating JAK2/STAT3 signaling.
    Gao F; Chen J; Zhang T; Liu N
    Exp Cell Res; 2022 Dec; 421(1):113360. PubMed ID: 36122769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lysophosphatidylcholine acyltransferase 1 promotes epithelial-mesenchymal transition of hepatocellular carcinoma via the Wnt/β-catenin signaling pathway.
    Shen L; Gu P; Qiu C; Ding WT; Zhang L; Cao WY; Li ZY; Yan B; Sun X
    Ann Hepatol; 2022; 27(3):100680. PubMed ID: 35108614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lysophosphatidylcholine acyltransferase 1 upregulation and concomitant phospholipid alterations in clear cell renal cell carcinoma.
    Du Y; Wang Q; Zhang X; Wang X; Qin C; Sheng Z; Yin H; Jiang C; Li J; Xu T
    J Exp Clin Cancer Res; 2017 May; 36(1):66. PubMed ID: 28494778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lysophosphatidylcholine acyltransferase 1 altered phospholipid composition and regulated hepatoma progression.
    Morita Y; Sakaguchi T; Ikegami K; Goto-Inoue N; Hayasaka T; Hang VT; Tanaka H; Harada T; Shibasaki Y; Suzuki A; Fukumoto K; Inaba K; Murakami M; Setou M; Konno H
    J Hepatol; 2013 Aug; 59(2):292-9. PubMed ID: 23567080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lysophosphatidylcholine acyltransferase1 overexpression promotes oral squamous cell carcinoma progression via enhanced biosynthesis of platelet-activating factor.
    Shida-Sakazume T; Endo-Sakamoto Y; Unozawa M; Fukumoto C; Shimada K; Kasamatsu A; Ogawara K; Yokoe H; Shiiba M; Tanzawa H; Uzawa K
    PLoS One; 2015; 10(3):e0120143. PubMed ID: 25803864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lysophosphatidylcholine Acyltransferase 1 Deficiency Promotes Pulmonary Emphysema via Apoptosis of Alveolar Epithelial Cells.
    Tanosaki T; Mikami Y; Shindou H; Suzuki T; Hashidate-Yoshida T; Hosoki K; Kagawa S; Miyata J; Kabata H; Masaki K; Hamamoto R; Kage H; Miyashita N; Makita K; Matsuzaki H; Suzuki Y; Mitani A; Nagase T; Shimizu T; Fukunaga K
    Inflammation; 2022 Aug; 45(4):1765-1779. PubMed ID: 35338433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LPCAT1 reprogramming cholesterol metabolism promotes the progression of esophageal squamous cell carcinoma.
    Tao M; Luo J; Gu T; Yu X; Song Z; Jun Y; Gu H; Han K; Huang X; Yu W; Sun S; Zhang Z; Liu L; Chen X; Zhang L; Luo C; Wang Q
    Cell Death Dis; 2021 Sep; 12(9):845. PubMed ID: 34518524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [HECTD2 Represses Cell Proliferation in Colorectal Cancer through Driving Ubiquitination and Degradation of LPCAT1].
    Ma L; Li DH; Xu Z
    Mol Biol (Mosk); 2022; 56(4):574-584. PubMed ID: 35964314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LPCAT1 enhances castration resistant prostate cancer progression via increased mRNA synthesis and PAF production.
    Han C; Yu G; Mao Y; Song S; Li L; Zhou L; Wang Z; Liu Y; Li M; Xu B
    PLoS One; 2020; 15(11):e0240801. PubMed ID: 33137125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Knockdown of LPCAT1 Repressed Hepatocellular Carcinoma Growth and Invasion by Targeting S100A11.
    Sun Q; Fu C; Liu J; Li S; Zheng J
    Ann Clin Lab Sci; 2023 Mar; 53(2):212-221. PubMed ID: 37094849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RNAi-mediated human Nestin silence inhibits proliferation and migration of malignant melanoma cells by G
    Yang XH; Xia T; Zhang J; Yang SF; Tang HX; Tang T; Huang ZC; Zhong YS; He F; Xiang AP
    J Huazhong Univ Sci Technolog Med Sci; 2017 Dec; 37(6):895-903. PubMed ID: 29270750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular cloning, tissue expression pattern, responses to different fatty acids and potential functions of lysophosphatidylcholine acyltransferase 1 (LPCAT1) in large yellow croaker (Larimichthys crocea).
    Zhang Y; Ding Y; Weng M; Cui K; Yang M; Mai K; Ai Q
    Gene; 2024 Feb; 896():148056. PubMed ID: 38042217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Up-regulation of lysophosphatidylcholine acyltransferase 1 (LPCAT1) is linked to poor prognosis in breast cancer.
    Lebok P; von Hassel A; Meiners J; Hube-Magg C; Simon R; Höflmayer D; Hinsch A; Dum D; Fraune C; Göbel C; Möller K; Sauter G; Jacobsen F; Büscheck F; Prien K; Krech T; Krech RH; von der Assen A; Wölber L; Witzel I; Schmalfeldt B; Geist S; Paluchoswski P; Wilke C; Heilenkötter U; Terracciano L; Müller V; Wilczak W; Burandt EC
    Aging (Albany NY); 2019 Sep; 11(18):7796-7804. PubMed ID: 31533087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lysophosphatidylcholine acyltransferase 1 (LPCAT1) overexpression in human colorectal cancer.
    Mansilla F; da Costa KA; Wang S; Kruhøffer M; Lewin TM; Orntoft TF; Coleman RA; Birkenkamp-Demtröder K
    J Mol Med (Berl); 2009 Jan; 87(1):85-97. PubMed ID: 18974965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of LPCAT1 enhances endometrial cancer stemness and metastasis by changing lipid components and activating the TGF/β-Smad2/3 signaling pathway.
    Zhao T; Sun R; Ma X; Wei L; Hou Y; Song K; Jiang J
    Acta Biochim Biophys Sin (Shanghai); 2022 Jun; 54(7):904-916. PubMed ID: 35880567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lysophosphatidylcholine Acyltransferase 1 (LPCAT1) Specifically Interacts with Phospholipid Transfer Protein StarD10 to Facilitate Surfactant Phospholipid Trafficking in Alveolar Type II Cells.
    Lin S; Ikegami M; Moon C; Naren AP; Shannon JM
    J Biol Chem; 2015 Jul; 290(30):18559-74. PubMed ID: 26048993
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lysophosphatidylcholine acyltransferase 1 (LPCAT1) upregulation in breast carcinoma contributes to tumor progression and predicts early tumor recurrence.
    Abdelzaher E; Mostafa MF
    Tumour Biol; 2015 Jul; 36(7):5473-83. PubMed ID: 25683484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.